By Li Zhongsheng and Song Xinyue King & Wood Mallesons’ IP group.

li_zhongshengIn January 2017, Beijing Sihuan Pharmaceutical Co., Ltd. (“Sihuan Pharm”), represented by a King & Wood Mallesons’ IP litigation team, succeeded in a patent infringement trial. The Inner Mongolia Hohhot Intermediate People’s Court (the “Court”) found that Qilu Pharmaceutical Co., Ltd. (“Qilu Pharmaceutical”)